OrthoPathways Group, Inc. (OPG) Announces New, Novel Instrument Named Bio-Aug FX
As OrthoPathways Group, Inc. (OPG) continues to pursue new technologies to aid the orthopedically challenged patient, the company reports that they are in the final development stages of a new, novel instrument, Bio-Aug FX, designed to extract stem cells from a patient’s own bone and then... - November 18, 2010
Press Releases 1 - 1 of 1